The two new CBD pet products are aimed at supporting aging pets with arthritis, anxiety, and reactivity.
Image | adobe.stock/watman
In a March 25, 2025, press release (1), Fusion CBD Products announced the launch of two new CBD pet products, Wiggles and Paws Dog Treats and Wiggles and Paws Pet Drops. The drops are flavorless, and the treats are made with apple sauce, almond butter, and coconut flour. The products are intended to help with healthy aging, such as offering arthritis support, and reducing anxiety and reactivity. As the press release noted, the lifespan of dogs and cats has increased 5.5% since 2013 and 11% since 2009, respectively, and with longer lifespans comes health issues due to aging. It also noted that consumers should consult their veterinarian about treatments for their pets.
Founded in 2019, Fusion CBD Products has partnered with FDA-registered and GMP-certified industrial facilities and uses organic, GMO-free hemp extract. Other products include CBD oil, gummies, topicals, and capsules.
Studies on CBD for use in treating pets for various conditions has been increasing. In a Cannabis Science and Technology interview, Robert Silver, DVM MS CVA, author of the book, Medical Marijuana and Your Pet and founder of the Well-Pet Dispensary, discussed the direction of new research in this area.
“We have had a couple of decent studies in epilepsy,” Dr. Silver explains. “One study used that blend of CBD and CBDA, and at fairly reasonably low dosages of about a milligram per each of those, or twice daily. And they were able to get reasonably good success, better success than the other study that was done at CSU by McGrath, in terms of treating dogs who have what we call ‘treatment resistant epilepsy,’ that's a very similar condition to what Charlotte Figi had, the child that got things started with Charlotte's Web and the whole interest in in CBD for these intractable epileptics. So that was good.”
In a separate interview, Joseph Wakshlag, DVM, PhD, DACVIM (nutrition), DACVSMR, and Chief Medical Officer of ElleVet Sciences, explains more on the research for cannabinoids interacting with the endocannabinoid system in pets. “I'm just going to add that we're still in the early phase of understanding this. This is a field that's, in essence, about six years old in veterinary medicine. Now, at least on the pain side for dogs, we have six papers that are peer reviewed publications, five of the six showing quite positive responses, and the sixth one saying, “maybe it's positive,” just because they didn't reach statistical significance. And then you just sit back and you say, “I have drugs I use in the veterinary world that I have no data on, I just use it because they use it in the human world.” And so it seems to me that we're sort of at the beginnings of understanding, and that things are looking quite positive for neuronal health type situations like seizures, we're looking at mobility being improved, we're looking at potentially dermatitis is being improved, allergic type diseases. So it's off to a really good start, and I can see it only growing from here.”
Reference